Search

everythinglearnresearchcommunity

for

Search:↓

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Blocking certain proteins on immune cells may help treat alopecia areata.

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

RTA 408 cream protects mice from radiation skin damage.

Adrenomedullin 2 stops cell growth and causes cell death in human hair follicles.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

A cream with a specific hormone blocker increases hair growth in mice.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Topical finasteride may help treat facial hirsutism in women.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.